Extrawell Pharmaceutical Holdings Limited operates within the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Extrawell Pharmaceutical Holdings Limited with three other
drug stores in Asia:
Ibl Healthcare Limited
sales of 1.19 billion Pakistan Rupees [US$11.30 million]
Immuno-Biological Laboratories Company Limited
(741.53 million Japanese Yen [US$6.56 million]
of which 74%
was Diagnosis & Reagent), and
Hong Kong Life Sciences and Technologies Group Ltd
(153.57 million Hong Kong Dollars [US$19.67 million]
of which 79%
was Trading Business).
During the year ended March of 2017, sales at
Extrawell Pharmaceutical Holdings Limited were HK$107.90 million (US$13.82 million).
decrease of 24.1%
versus 2016, when the company's sales were HK$142.20 million.
Contributing to the drop in overall sales was the 36.1% decline
in Trading, from HK$99.31 million to HK$63.43 million.
However, these declines were partially offset by the increase in sales of
Manufacturing (up 3.7% to HK$44.48 million)